These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30038510)

  • 21. Medicare Beneficiaries Face Growing Out-Of-Pocket Burden For Specialty Drugs While In Catastrophic Coverage Phase.
    Trish E; Xu J; Joyce G
    Health Aff (Millwood); 2016 Sep; 35(9):1564-71. PubMed ID: 27605634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers to Utilizing Medicaid Smoking Cessation Benefits.
    Knox B; Mitchell S; Hernly E; Rose A; Sheridan H; Ellerbeck EF
    Kans J Med; 2017 Nov; 10(4):1-11. PubMed ID: 29472979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Policies Affecting Medicaid Beneficiaries' Smoking Cessation Behaviors.
    Brantley EJ; Greene J; Bruen BK; Steinmetz EP; Ku LC
    Nicotine Tob Res; 2019 Jan; 21(2):197-204. PubMed ID: 29522120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Increasing Coverage for Select Smoking Cessation Therapies With no Out-of-Pocket Cost Among the Medicaid Population in Alabama, Georgia, and Maine.
    Athar H; Chen ZA; Contreary K; Xu X; Dube SR; Chang MH
    J Public Health Manag Pract; 2016; 22(1):40-7. PubMed ID: 26131658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription Smoking-Cessation Medication Fills and Spending, 2009-2019.
    Jackson SL; Tsipas S; Yang PK; Ritchey MD; Loustalot F; Wozniak G; Wang X
    Am J Prev Med; 2022 Jun; 62(6):e351-e355. PubMed ID: 35597571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healthcare costs around the time of smoking cessation.
    Hockenberry JM; Curry SJ; Fishman PA; Baker TB; Fraser DL; Cisler RA; Jackson TC; Fiore MC
    Am J Prev Med; 2012 Jun; 42(6):596-601. PubMed ID: 22608375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.
    Cadier B; Durand-Zaleski I; Thomas D; Chevreul K
    PLoS One; 2016; 11(2):e0148750. PubMed ID: 26909802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimates of costs for modelling return on investment from smoking cessation interventions.
    Trapero-Bertran M; Leidl R; Muñoz C; Kulchaitanaroaj P; Coyle K; Präger M; Józwiak-Hagymásy J; Cheung KL; Hiligsmann M; Pokhrel S;
    Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):32-41. PubMed ID: 29532538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs and spillover effects of private insurers' coverage of hepatitis C treatment.
    Moreno GA; Mulligan K; Huber C; Linthicum MT; Dreyfus D; Juday T; Marx SE; Gonzalez YS; Brookmeyer R; Lakdawalla DN
    Am J Manag Care; 2016 May; 22(6 Spec No.):SP236-44. PubMed ID: 27266954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Savings needed to fund health insurance and health care expenses in retirement: findings from a simulation model.
    Fronstin P; Salisbury D; VanDerhei J
    EBRI Issue Brief; 2008 May; (317):1-2, 4-27. PubMed ID: 18630312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-benefit analysis of funding smoking cessation before surgery.
    Jiménez-Ruiz CA; Martín V; Alsina-Restoy X; de Granda-Orive JI; de Higes-Martínez E; García-Rueda M; Genovés-Crespo M; López-García C; Lorza-Blasco JJ; Márquez FL; Ramos-Pinedo Á; Riesco-Miranda JA; Signes-Costa J; Solano-Reina S; Vaquero-Lozano P; Rejas J
    Br J Surg; 2020 Jul; 107(8):978-994. PubMed ID: 32372474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription drug spending by payer: Implications for managed care.
    Chavehpour Y; Balkrishnan R; Segel JE
    Explor Res Clin Soc Pharm; 2024 Mar; 13():100406. PubMed ID: 38312738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.
    Yazdany J; Dudley RA; Chen R; Lin GA; Tseng CW
    Arthritis Rheumatol; 2015 Jun; 67(6):1474-80. PubMed ID: 25900105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare financing systems for increasing the use of tobacco dependence treatment.
    Reda AA; Kotz D; Evers SM; van Schayck CP
    Cochrane Database Syst Rev; 2012 Jun; (6):CD004305. PubMed ID: 22696341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smoking cessation in a blue-collar population: results from an evidence-based pilot program.
    Ringen K; Anderson N; McAfee T; Zbikowski SM; Fales D
    Am J Ind Med; 2002 Nov; 42(5):367-77. PubMed ID: 12382249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.
    Getsios D; Marton JP; Revankar N; Ward AJ; Willke RJ; Rublee D; Ishak KJ; Xenakis JG
    Pharmacoeconomics; 2013 Sep; 31(9):767-80. PubMed ID: 23821436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act.
    Bonakdar Tehrani A; Cunningham PJ
    Med Care; 2017 Jan; 55(1):43-49. PubMed ID: 27547949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kentucky's Smoking Cessation Quitline: Annual Estimated Return on Investment to Employers.
    Pauly N; Talbert J; Parsley S; Gray B; Hahn EJ
    Am J Health Promot; 2019 Feb; 33(2):285-288. PubMed ID: 29969913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.